Anastrozole: beside an established treatment under test
21 studies: an approved drug, surgery or radiation is what the study tests. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast CancerCompletedNCT04075604Phase 2Results postedHow we knowReport a problem
- 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.TerminatedNCT02000596Phase 2Results postedHow we knowReport a problem
- A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast CancerCompletedNCT01216176Phase 1/2Results postedHow we knowReport a problem
- Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast CancerTerminatedNCT01151215Phase 2Results postedHow we knowReport a problem
- Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast CancerCompletedNCT00570323Phase 2Results postedHow we knowReport a problem
- Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs AnastrozoleTerminatedNCT00543127Phase 3Results postedHow we knowReport a problem
- Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast CancerTerminatedNCT00481845Phase 2Results postedHow we knowReport a problem
- Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast CancerCompletedNCT00357110Phase 2Results postedHow we knowReport a problem
- Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyCompletedNCT00256698Phase 3Results postedHow we knowReport a problem
- S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerCompletedNCT00075764Phase 3Results postedHow we knowReport a problem
- A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast CancerCompletedNCT00022672Phase 3Results postedHow we knowReport a problem
- Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast CancerTerminatedNCT04113863Phase 2How we knowReport a problem
- Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)Active, not recruitingNCT02730923Phase 1/2How we knowReport a problem
- Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABCWithdrawnNCT02140437Phase 2How we knowReport a problem
- Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast CancerStatus unknownNCT00902954Phase 3How we knowReport a problem
- Faslodex Advanced Breast Cancer Local Chinese StudyCompletedNCT00327769Phase 3How we knowReport a problem
- Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa StudyCompletedNCT00255463Phase 2How we knowReport a problem
- Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast CancerTerminatedNCT00206414Phase 2How we knowReport a problem
- Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)CompletedNCT00081510Phase 2How we knowReport a problem
- Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast CancerCompletedNCT00077025Phase 2How we knowReport a problem
- Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast CancerCompletedNCT00066378Phase 2How we knowReport a problem